SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-073610
Filing Date
2010-03-31
Accepted
2010-03-31 17:08:56
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 882409
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1683
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9423
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9395
5 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3538
6 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3538
7 GRAPHIC g82252pg044.jpg GRAPHIC 84023
  Complete submission text file 0001193125-10-073610.txt   1027346
Mailing Address 220 MIRACLE MILE SUITE 234 CORAL GABLES FL 33134
Business Address 220 MIRACLE MILE SUITE 234 CORAL GABLES FL 33134 (305) 529-2522
Catalyst Pharmaceutical Partners, Inc. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33057 | Film No.: 10720255
SIC: 2834 Pharmaceutical Preparations